Cost evaluation of therapeutic drug monitoring of gentamicin at a teaching hospital in Malaysia

Background: Therapeutic drug monitoring (TDM) makes use of serum drug concentrations as an adjunct to decision-making. Preliminary data in our hospital showed that approximately one-fifth of all drugs monitored by TDM service were gentamicin. Objective: In this study, we evaluated the costs as...

Full description

Bibliographic Details
Main Authors: Mohamed Ibrahim, Mohamed Izham, Ahmed Abdelrahim, Hisham Elhag, Ab Rahman, Ab Fatah
Format: Article
Language:English
Published: Centro de Investigaciones y Publicaciones Farmaceuticas 2014
Subjects:
Online Access:http://eprints.usm.my/38538/1/Cost_evaluation_of_therapeutic_drug_monitoring_of_gentamicin_at_a_teaching_hospital_in_Malaysia.pdf
_version_ 1825833873334861824
author Mohamed Ibrahim, Mohamed Izham
Ahmed Abdelrahim, Hisham Elhag
Ab Rahman, Ab Fatah
author_facet Mohamed Ibrahim, Mohamed Izham
Ahmed Abdelrahim, Hisham Elhag
Ab Rahman, Ab Fatah
author_sort Mohamed Ibrahim, Mohamed Izham
collection USM
description Background: Therapeutic drug monitoring (TDM) makes use of serum drug concentrations as an adjunct to decision-making. Preliminary data in our hospital showed that approximately one-fifth of all drugs monitored by TDM service were gentamicin. Objective: In this study, we evaluated the costs associated with providing the service in patients with bronchopneumonia and treated with gentamicin. Methods: We retrospectively collected data from medical records of patients admitted to the Hospital Universiti Sains Malaysia over a 5-year period. These patients were diagnosed with bronchopneumonia and were on gentamicin as part of their treatment. Five hospitalisation costs were calculated; (i) cost of laboratory and clinical investigations, (ii) cost associated with each gentamicin dose, (iii) fixed and operating costs of TDM service, (iv) cost of providing medical care, and (v) cost of hospital stay during gentamicin treatment. Results: There were 1920 patients admitted with bronchopneumonia of which 67 (3.5%) had TDM service for gentamicin. Seventy-three percent (49/67) patients were eligible for final analysis. The duration of gentamicin therapy ranged from 3 to 15 days. The cost of providing one gentamicin assay was MYR25, and the average cost of TDM service for each patient was MYR104. The average total hospitalisation cost during gentamicin treatment for each patient was MYR442 (1EUR approx. MYR4.02). Conclusion: Based on the hospital perspective, in patients with bronchopneumonia and treated with gentamicin, the provision of TDM service contributes to less than 25% of the total cost of hospitalization.
first_indexed 2024-03-06T15:14:18Z
format Article
id usm.eprints-38538
institution Universiti Sains Malaysia
language English
last_indexed 2024-03-06T15:14:18Z
publishDate 2014
publisher Centro de Investigaciones y Publicaciones Farmaceuticas
record_format dspace
spelling usm.eprints-385382018-01-25T02:51:30Z http://eprints.usm.my/38538/ Cost evaluation of therapeutic drug monitoring of gentamicin at a teaching hospital in Malaysia Mohamed Ibrahim, Mohamed Izham Ahmed Abdelrahim, Hisham Elhag Ab Rahman, Ab Fatah RS1-441 Pharmacy and materia medica Background: Therapeutic drug monitoring (TDM) makes use of serum drug concentrations as an adjunct to decision-making. Preliminary data in our hospital showed that approximately one-fifth of all drugs monitored by TDM service were gentamicin. Objective: In this study, we evaluated the costs associated with providing the service in patients with bronchopneumonia and treated with gentamicin. Methods: We retrospectively collected data from medical records of patients admitted to the Hospital Universiti Sains Malaysia over a 5-year period. These patients were diagnosed with bronchopneumonia and were on gentamicin as part of their treatment. Five hospitalisation costs were calculated; (i) cost of laboratory and clinical investigations, (ii) cost associated with each gentamicin dose, (iii) fixed and operating costs of TDM service, (iv) cost of providing medical care, and (v) cost of hospital stay during gentamicin treatment. Results: There were 1920 patients admitted with bronchopneumonia of which 67 (3.5%) had TDM service for gentamicin. Seventy-three percent (49/67) patients were eligible for final analysis. The duration of gentamicin therapy ranged from 3 to 15 days. The cost of providing one gentamicin assay was MYR25, and the average cost of TDM service for each patient was MYR104. The average total hospitalisation cost during gentamicin treatment for each patient was MYR442 (1EUR approx. MYR4.02). Conclusion: Based on the hospital perspective, in patients with bronchopneumonia and treated with gentamicin, the provision of TDM service contributes to less than 25% of the total cost of hospitalization. Centro de Investigaciones y Publicaciones Farmaceuticas 2014-03 Article PeerReviewed application/pdf en http://eprints.usm.my/38538/1/Cost_evaluation_of_therapeutic_drug_monitoring_of_gentamicin_at_a_teaching_hospital_in_Malaysia.pdf Mohamed Ibrahim, Mohamed Izham and Ahmed Abdelrahim, Hisham Elhag and Ab Rahman, Ab Fatah (2014) Cost evaluation of therapeutic drug monitoring of gentamicin at a teaching hospital in Malaysia. Pharmacy Practice, 12 (1). pp. 1-6. ISSN 1886-3655 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955865/
spellingShingle RS1-441 Pharmacy and materia medica
Mohamed Ibrahim, Mohamed Izham
Ahmed Abdelrahim, Hisham Elhag
Ab Rahman, Ab Fatah
Cost evaluation of therapeutic drug monitoring of gentamicin at a teaching hospital in Malaysia
title Cost evaluation of therapeutic drug monitoring of gentamicin at a teaching hospital in Malaysia
title_full Cost evaluation of therapeutic drug monitoring of gentamicin at a teaching hospital in Malaysia
title_fullStr Cost evaluation of therapeutic drug monitoring of gentamicin at a teaching hospital in Malaysia
title_full_unstemmed Cost evaluation of therapeutic drug monitoring of gentamicin at a teaching hospital in Malaysia
title_short Cost evaluation of therapeutic drug monitoring of gentamicin at a teaching hospital in Malaysia
title_sort cost evaluation of therapeutic drug monitoring of gentamicin at a teaching hospital in malaysia
topic RS1-441 Pharmacy and materia medica
url http://eprints.usm.my/38538/1/Cost_evaluation_of_therapeutic_drug_monitoring_of_gentamicin_at_a_teaching_hospital_in_Malaysia.pdf
work_keys_str_mv AT mohamedibrahimmohamedizham costevaluationoftherapeuticdrugmonitoringofgentamicinatateachinghospitalinmalaysia
AT ahmedabdelrahimhishamelhag costevaluationoftherapeuticdrugmonitoringofgentamicinatateachinghospitalinmalaysia
AT abrahmanabfatah costevaluationoftherapeuticdrugmonitoringofgentamicinatateachinghospitalinmalaysia